We are a US-based biotech company with over 20 years of research into the Klotho gene, pioneering advanced genetic technologies to shape the future of regenerative medical aesthetics. Our vision is to transform skin rejuvenation through second-generation growth factors, while our mission is to revolutionize cosmetics with integrity, quality, and excellence.

THE KLOTHO GENE SECRET
The Klotho gene is the first documented aging suppressor gene in mammals that can delay aging when overexpressed and accelerate aging when disrupted.

The Klotho gene was originally identified as a gene mutated in a mouse strain that exhibits a syndrome resembling human aging including a shortened lifespan, skin atrophy, muscle atrophy, neuronal degeneration, arteriosclerosis, osteoporosis, and pulmonary emphysema.

In contrast overexpression of the Klotho gene extends the lifespan of the mouse living 31% longer and remaining younger in all systems. FOXO1 is increased resulting in an increase is super oxide dismutase which serves to protect cells from oxidative stress.

PATENTED GROUNDBREAKING MANUFACTURING
Patented process utilizing advanced genetic engineering techniques to modify adult mesenchymal stem cells upregulating the Klotho gene, leading to the production of the Klotho protein and second-generation growth factors using clean and sustainably sourced ingredients.

CLINICAL TRIALS
Klotho Skin is the first skincare line designed to harness the power of the age-suppressing Klotho protein utilizing the cell-conditioned medium from genetically modified stem cells.

Klotho Skin

Org chart

Teams

Offices

Klotho Skin

Org chart

Teams

Offices

Related companies